Product NDC: | 51808-203 |
Proprietary Name: | SIncalide |
Non Proprietary Name: | Sincalide |
Active Ingredient(s): | 3 ug/1 & nbsp; Sincalide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51808-203 |
Labeler Name: | AnazaoHealth Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120619 |
Package NDC: | 51808-203-01 |
Package Description: | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 PACKAGE (51808-203-01) |
NDC Code | 51808-203-01 |
Proprietary Name | SIncalide |
Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 PACKAGE (51808-203-01) |
Product NDC | 51808-203 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sincalide |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120619 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | AnazaoHealth Corporation |
Substance Name | SINCALIDE |
Strength Number | 3 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC] |